The Simpson Querrey Center for Neurogenetics studies genetic neurological diseases and promotes integrated and multidisciplinary approaches to facilitate early discovery and development of targeted therapies for patients with neurological disorders. Our initial focus has been on neurodegenerative diseases for which conventional drug development has been particularly challenging, primarily due to the lack of accurate molecular targets and biomarkers.
Collaborative efforts have been established across academic and government institutions, industry and voluntary organizations to develop shared resources for discovery research and clinical trials. We believe that through these collaborations we have the potential to find treatments for many incurable neurological disorders. We owe this to those who suffer from these disorders and to patients’ families.
We invite you to contact us for more information.
Dimitri Krainc, MD, PhD
Director, Simpson Querrey Center for Neurogenetics
Chair, Department of Neurology
Aaron Montgomery Ward Professor of Neurology